Position in ELAN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$130,588,679
-$64,229,564 QoQ
Shares Held
5,306,326
-34.8% QoQ
Ownership
1.06%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#18
of 515 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 96%
None 4%
Common Shares in ELAN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Invesco Ltd. holds $1,945,758,306 across 45 Drug Manufacturers - Specialty & Generic names. ELAN ranks #5 (6.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
5,523,018 | $396,884,069 | |
| 2 | VTRS |
Viatris Inc
|
20,771,275 | $329,847,840 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
473,109 | $256,344,645 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
1,077,317 | $181,571,000 | |
| 5 | ELAN |
Elanco Animal Health Inc
This page
|
5,306,326 | $130,588,679 | |
| 6 | TEVA |
Teva Pharmaceutical Industries Ltd
|
3,430,011 | $116,208,767 | |
| 7 | INDV |
Indivior Pharmaceuticals, Inc.
|
1,842,983 | $75,617,590 | |
| 8 | COLL |
Collegium Pharmaceutical, Inc
|
1,882,499 | $68,146,461 |
All Filings in ELAN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $130,588,679 | 5,306,326 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $194,818,243 | 8,141,172 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $108,375,903 | 4,789,037 | Shares | Defined | 2026-02-19 | |
| 2025-09-30 | $22,119,801 | 1,098,302 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $8,135,741 | 569,730 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $5,830,250 | 555,262 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $6,495,692 | 536,391 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $7,126,968 | 485,158 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $9,681,229 | 670,910 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $27,205,244 | 1,671,084 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $11,745,877 | 788,314 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $5,710,210 | 508,026 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $4,663,602 | 463,579 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $4,764,783 | 506,892 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $4,915,003 | 402,210 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $4,935,541 | 397,707 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $7,946,240 | 404,801 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $10,253,237 | 392,995 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $9,893,606 | 348,612 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $11,196,800 | 351,107 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $11,336,308 | 326,789 | Shares | Defined | 2021-08-17 | |
| 2021-03-31 | $8,525,125 | 289,478 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $7,337,428 | 239,238 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $18,414,666 | 659,315 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $43,771,812 | 2,040,644 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $234,231,125 | 10,461,417 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||